Chromic citrate

DB14526ExperimentalSmall molecule

Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN), to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency...

Chemical structure of Chromic citrate
Mechanism
Curator reviewed · 6 references
Primary indication
Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN), to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.Curator reviewed
Formula / weight
C6H5CrO7 · 241.095 g/mol (avg)

Resolves to

Clinical / RWD
Structure
InChIKeySWXXYWDHQDTFSU-UHFFFAOYSA-KSMILES[Cr+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
733Drug interactionsStructured to mechanism, not free text
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Chromic citrate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account